Proactive Investors China - The web's leading portal for China stocks - Orthocell granted key US divisional patent for CelGro®
2021-02-15 by Proactive Australia Orthocell Ltd (ASX:OCC) has received a new US divisional patent for CelGro® that covers the method of manufacture of collagen medical devices and as an aid in the surgical repair of soft tissue injuries. The patents entitled ‘Method for Producing a Collagen Membrane and Uses Thereof' provides additional important intellectual property (IP) to protect the CelGro® platform for soft tissue regeneration and repair applications and expires in June 2033. Orthocell has already been granted patents for CelGro® in the US, Canada, Europe, China, Japan, Singapore,...
Source: proactiveinvestors.com.hk